IPO Profile: KemPharm Inc

The Iowa drug developer is backed by Dewaay Capital Management

1 May 2015•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.